Loading the section…
The price of Bioventus Inc. (BVS) on October 9, 2026 is 13.06 USD, +2.96% on the day. Over 52 weeks the stock traded between 6.37 USD and 15.89 USD; the price now sits 70% of the way up that range. Over the past year the price changed by +93.27%. The P/E ratio is 32.1, which is above the sector median (25.0). Market capitalization is 914.66 million USD, rank 33 among 98 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): +98.86 %
Bioventus Inc. trades on Nasdaq under the ticker BVS. The company belongs to the Health care sector. The trading history on this page starts on 11 February 2021.
Over the past 52 weeks BVS has traded between 6.37 $ and 15.89 $. As of 9 October 2026 the price stood 70.30 % of the way from the 52-week low to the high.
Over one year BVS shares rose 93.27 %; over six months they rose 44.21 %. Volatility over 90 days is 52.27 %. Dividends are not included: this is price change only, as of 9 October 2026.
BVS trades at a price-to-earnings ratio of 32.1, above the sector median of 25.0. Price to sales is 1.6, below the sector median of 4.0. Price to book is 4.8, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 12.82 | 13.11 | 12.64 | 13.07 | 273,300 |
| 8 October 2026 | 12.72 | 12.77 | 12.52 | 12.69 | 385,600 |
| 7 October 2026 | 13.00 | 13.36 | 12.75 | 12.77 | 365,200 |
| 6 October 2026 | 13.50 | 13.62 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
Address:4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703, US
Bioventus Inc. reported revenue of 576M $ and net income of 28M $ over the last four quarters. Net margin is 4.94 %. Revenue changed by +1.52 % year over year. Earnings per share are 0.41 $. Market capitalisation is 915M $.
BVS has a return on equity of 15.08 %, above the sector median of −41.68 %. Return on assets is 4.38 %, above the sector median of −32.11 %. Operating margin is 9.98 %, above the sector median of −26.84 %.
| 328M |
| DXCMDexCom, Inc. | 84.11 | −0.36 % | 324M |
| MDLNMedline Inc. | 36.26 | +1.45 % | 297M |
| RMDResMed Inc. | 230.05 | +1.46 % | 271M |
| PODDInsulet Corporation | 135.28 | +0.60 % | 244M |
| 13.07 |
| 13.10 |
| 295,500 |
| 5 October 2026 | 13.13 | 13.58 | 13.07 | 13.52 | 356,800 |
| 2 October 2026 | 13.52 | 13.52 | 13.02 | 13.13 | 362,400 |
| 1 October 2026 | 13.68 | 13.79 | 13.39 | 13.45 | 509,300 |
| 30 September 2026 | 14.01 | 14.01 | 13.57 | 13.63 | 461,100 |
| 29 September 2026 | 13.95 | 14.15 | 13.78 | 14.00 | 449,100 |
| 28 September 2026 | 13.81 | 14.10 | 13.64 | 14.02 | 588,700 |
| 25 September 2026 | 13.56 | 13.94 | 13.42 | 13.81 | 455,400 |
| 24 September 2026 | 13.64 | 13.64 | 13.36 | 13.52 | 331,300 |
| 23 September 2026 | 13.56 | 13.64 | 13.21 | 13.61 | 329,600 |
| 22 September 2026 | 13.38 | 13.67 | 13.35 | 13.65 | 429,400 |
| 21 September 2026 | 13.04 | 13.47 | 12.76 | 13.31 | 473,100 |
| 18 September 2026 | 12.49 | 12.99 | 12.34 | 12.91 | 828,200 |
| 17 September 2026 | 13.30 | 13.30 | 12.63 | 12.63 | 385,500 |
| 16 September 2026 | 13.02 | 13.33 | 12.88 | 13.20 | 546,000 |
| 15 September 2026 | 13.05 | 13.05 | 12.68 | 13.00 | 463,400 |
| 14 September 2026 | 13.00 | 13.28 | 12.92 | 13.16 | 363,400 |